One unit of enzyme activity was the amount of enzyme required for the production of one micromole
of reducing sugar in one minute at 40oC (Miller, 1959).
One unit of activity represents deamination of one micromole
of adenosine/ min at 370 c and is expressed as 1 U/L.
One unit of enzyme activity is defined as the amount of enzyme that liberated one micromole
of reducing sugar (glucose) per min.
Activity of enzyme is the amount of micromole
of a substrate to transform into product by enzyme per mL per minute under standard conditions.
The antioxidant capacity based on the DPPH free radical scavenging ability of the extract was expressed as micromole
of Trolox equivalents (TE) per gram sample by using a calibration graph Trolox concentration range of dry weight (DW) (Figure 3).
International Journal of Microbiology Micromole
, 55: 39-46.
" Physicochemical properties of starch-CMC-Nano clay biodegradable films" Boil Micromole
, 46: 1-5.
Higher rates of fetal complication have been reported if serum bile acids are above 40 micromole
per liter8 or if women had jaundice along with pruritus.
A unit of activity is equal to an amount of enzyme causes formation of 1 micromole
of arginine per 1 min of incubation; [DELTA]E--extinctions difference between experimental and control sample; n--dilution of enzymatic solution; 1.6--the total volume of sample; 2 and 5--recalculation for the whole mixer under intubation; 100--calculation on 100 ml of serum; 0.1--volume of enzymatic solution; T time of incubation, min; 174.2--molecular mass of arginine; k--coefficient of conversion of extinction amount to micromole
Voraxaze is used for the treatment of toxic plasma methotrexate concentrations (>1 micromole
per litre) in patients with delayed methotrexate clearance due to impaired renal function, including the chemotherapy treatment given to patients with certain types of cancer, such as osteosarcoma, leukemia, and lymphoma.
Researchers analyzed their blood and found that for every increase of 1 micromole
per liter of vitamin B12, the risk of AD dropped by 2 percent.
However, it must be noted that in the ASTRAL trial, although the patients enrolled were sicker than those usually included in the studies (mean baseline serum creatinine around 2 mg/dl), were not taking antiplatelet therapy at the time of stenting in a significant proportion (up to 24%) and exhibited a mild renal stenosis (<70%) in up to 40%, there was a strong trend toward a decreased rate of renal impairment in the revascularization group compared to the medically treated group (difference in the slope of the reciprocal of the serum creatinine level 0.06x10-3 liters per micromole
per year, p=0.06).